Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

See introductory video with welcome to the ICR 

See full video covering all of ICR and its Departments 

Publication overview

Annual reports


Current news and events

Announcement from the Reseach Council of Norway:Innovation Project for the Public Sector

The Research Council of Norway is announcing up to NOK 160 million in R&D support for Innovation Projects for the Public Sector. A funding of NOK 49 million is available for innovation in and for the public sector that contributes to good solutions to specific challenges in the health and welfare services. 

Funding scale: NOK 3 000 000-7 000 000

Application deadline: 15 September 2021

Ceremony available via YouTube:Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2020

The award winners
The award winners

In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital rewards outstanding publications every half-year. 

Six research groups were awarded for their excellent papers published the second half-year of 2020 during a ceremony on June 11th.  Each group received NOK 50.000 for use in further research, and the prize winners gave  short presentations of their main findings. These are available via YouTube.

From the South-Eastern Norway Regional Health Authority:Announcement of regional research funding for 2022

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF) announces approximately NOK 130 million for health research funding in the region.

The call is open to all research areas. A portion of the funds will be targeted at projects within four thematic areas.

Application deadline is Thursday, September 2nd 2021 16:00.

Centre for Advanced Cell and Gene therapy launched

From left: Dag Josefsen, Johanna Olweus and Karl-Johan Malmberg
From left: Dag Josefsen, Johanna Olweus and Karl-Johan Malmberg

Cell and gene therapy form two of the most dynamic research areas world-wide and provide fundamentally new therapies for diseases without available treatment. A donor consortium consisting of Svanhild and Arne Must´s Foundation for Medical Research (lead donor), RADFORSK oncology research fund and the Norwegian Cancer Society, has committed 50 MNOK to form a Centre for Advanced Cell and Gene therapy (ACT Centre) located in clean room facilities at the OUH. The launching of the centre was covered by the Norwegian Broadcasting Corporation (NRK) May 2nd.

Annual Report from the Institute for Cancer Research for 2020

The Annual Report from the Institute for Cancer Research for 2020 is now published.
Institute head Kjetil Taskén says: "We have kept the activity up through the pandemic based on the production numbers. You can read about the exciting research by almost 400 people in 25 research groups and 6 core facilities at the ICR. Activities in the CanCell CoE, two KG Jebsen Centres and two OUH strategic research areas and other activities in precision medicine and cell therapy where our researchers are involved are also covered."

Units and subpages

View all subunitsHide all subunits